Commonly reported adverse effects include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation were the most frequently reported side effects, particularly during dose escalation
We note that HRAs are a promise by an employer to pay up to a specified amount and that many employees will not use the full amount available to their HRA in a year, so adding the employer premium contribution amount and the HRA contribution represents an upper bound for employer liability
Related Resources Explore additional peptide therapy resources to optimize your metabolic health journey: Semaglutide GLP-1 receptor agonist for appetite control and glucose regulation Tirzepatide Dual GIP/GLP-1 agonist for enhanced metabolic support CJC-1295/Ipamorelin Growth hormone secretagogue for muscle preservation and recovery Tesamorelin GHRH analog targeting visceral adipose tissue reduction Schedule a Peptide Therapy Consultation Discuss your metabolic optimization goals with our medical team
Refrigerate for optimal quality, and keep it away from heat, light, and humidity otherwise
This results in an extremely short half-life of only 2 minutes after intravenous administration
Many people regain weight when they stop treatment abruptly without a maintenance plan